Episode

Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement

Podcast
The IMID Forum
Published
Jun 18, 2026
Duration seconds
783
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/discussing-psa-personalising
Audio
https://feeds.soundcloud.com/stream/2341604945-imidforum-discussing-psa-personalising.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement
Markdown
/podcast/the-imid-forum-981476/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversation explores how patients with differing levels of baseline disease activity may require different degrees of improvement before perceiving treatment benefit, highlighting the potential for more personalised treatment targets and shared decision making in PsA.